Giving Immunotherapy Cells Resilience to Pass the 'Stress Test'

T cells used in immunotherapy treatments can get exhausted and shut down by fighting cancer cells and tumors. Using a CRISPR-based edit on these cells’ genomes, researchers at UCSF and Gladstone Institutes have rendered the therapeutic cells more resilient against tumors.

Related Keywords

Germany ,Stanford ,California ,United States ,Munich ,Bayern ,Fresno ,San Francisco ,Nupura Kale ,Bence Daniel ,Shane Vedova ,Julia Belk ,Shannon Lange ,Yan Yi Chen ,Marie Luetke Eversloh ,Williama Nyberg ,Theodorel Roth ,Zhongmei Li ,Eric Shifrut ,Scott Kogan ,Brooke Prinzing ,Dalia Haydar ,Giedre Krenciute ,Alex Marson ,Justin Eyquem ,Sagarp Bapat ,Kevin Shannon ,Alan Ashworth Julia Carnevale ,Jorge Iba ,Stefanie Bachl ,Alex Ritter ,Julia Carnevale ,Tobias Feuchtinger ,Gillian Griffiths ,Hideho Okada ,Patrick Oleary ,Franziska Blaeschke ,Bindu Hegde ,Morgane Diolaiti ,Jennifer Lippincott Schwartz ,Stephen Gottschalk ,Alan Ashworth ,Ansuman Satpathy ,University Of California ,School Of Medicine ,Jude Children Research Hospital ,Institute Of Genomic Immunology ,National Institutes Of Health ,Cancer Research Institute ,University Hospital ,Parker Institute For Cancer Immunotherapy ,Tel Aviv University ,Department Of Medicine ,Helen Diller Family Comprehensive Cancer Center ,National Institutes ,Gladstone Institutes ,Genomic Immunology ,Diller Family Comprehensive Cancer ,Tel Aviv ,Jude Children ,Research Hospital ,Patricko Leary ,Alejandro Allo Anido ,Maelys Born Bony ,Hauner Children ,Parker Institute ,